Author:
Amiel J. L.,Sancho-Garnier H.,Vandenbrouck C.,Eschwege F.,Droz J. P.,Schwaab G.,Wibault P.,Stromboni M.,Rey A.
Publisher
Springer Berlin Heidelberg
Reference10 articles.
1. Amiel, J. L., Berardet, M.: Factor time for active immunotherapy after cytoreductive chemotherapy. Eur. J. Cancer. 10, 89 (1974).
2. Amiel, J. L., Sancho, H., Vandenbrouck, C.: Note préliminaire sur un essai d’immunotherapie active par le BCG pour des tumeurs ORL. Bull. Cancer. 63, 287–288 (1976).
3. Eibler, F. R., Morton, D. L., Holmes, E. D., Sparks, F. C., Ramming, K. P.: Adjuvant immunotherapy with BCG in treatment of regional-lymphnode metastasis from malignant melanoma. N. Engl. J. Med. 294, 237–240 (1976).
4. International Registry of Tumor Immunotherapy: Compendium of Tumor Immunotherapy Protocols. N° 5. September 1977.
5. Jewell, W. R., Thomas, J. H., Sterchi, J. M., Morse, P. A., Humphrey, L. J.: Critical Analysis of Treatment of Stage II en Stage III Melanoma Patients with immunotherapy. Ann. Surg. 183, 543–549 (1976).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献